glp 1 gip vs tirzepatide Comparison between GLP-1 RA and the GLP-1/GIP dual agonist GLP-1 and GIP-1 receptor agonists

The route selection is what matters

The fact that the majority of L-cells are located distally in the small intestine has prompted attempts to use -glucosidase inhibitors to prevent rapid digestion of starch and complex carbohydrates, thereby moving intestinal contents downwards and resulting in preferential digestion and absorption in the lower jejunum or ileum, where L-cells are most prevalent

It's unavoidable hard efforts produce free radicals as a byproduct of energy metabolism, and the accumulated oxidative load of a heavy training block puts consistent pressure on your cells, your immune system, and your liver

Referensi: Mayo Clinic